Transdigm Group Stock Price, News & Analysis

TransDigm Group (NYSE: TDG) has announced a special cash dividend of $75.00 per share and cash dividend equivalent payments on eligible vested options. The record date is set for October 4, 2024, with payment scheduled for October 18, 2024. Additionally, the company's subsidiary, TransDigm Inc., has successfully received funding for a $3 billion incremental debt, comprising:

• $1.5 billion in new term loans maturing in 2032 at TERM SOFR plus 2.5% interest
• $1.5 billion in new Senior Secured Notes maturing in 2033 at 6.0% interest

CEO Kevin Stein stated that this special dividend aligns with their goal of delivering returns comparable to well-performing private equity funds while maintaining public market liquidity. The company expects to maintain significant liquidity and financial flexibility after the dividend payout.

TransDigm Group (NYSE: TDG) reported strong fiscal 2024 third quarter results, with net sales up 17% to $2,046 million and net income increasing 31% to $461 million. The company's EBITDA As Defined rose 19% to $1,091 million, with a margin of 53.3%. TransDigm completed acquisitions of SEI Industries, CPI Electron Device Business, and Raptor Scientific, deploying over $2.2 billion in capital. The company raised its fiscal 2024 guidance, now expecting net sales between $7,870-$7,930 million and EBITDA As Defined of $4,100-$4,160 million. This outlook is based on projected growth in commercial OEM (20%), commercial aftermarket (mid-teens), and defense (high-teens) revenue.

TransDigm Group Incorporated (NYSE: TDG) has successfully completed its acquisition of Raptor Labs Holdco, (Raptor Scientific) for approximately $655 million in cash, including certain tax benefits. The acquisition, financed through cash on hand, was previously announced on May 28, 2024.

Raptor Scientific is a leading global manufacturer of complex test and measurement solutions, primarily serving the aerospace and defense end markets. The company's products are highly engineered, proprietary components with significant aftermarket content and a strong presence across major aerospace and defense platforms. Raptor Scientific is expected to generate approximately $90 million in revenue for the calendar year ending December 31, 2024.

TransDigm Group Incorporated (NYSE: TDG) has announced its plans to release its fiscal 2024 third quarter earnings report before the market opens on Tuesday, August 6, 2024. Following the release, the company will host a conference call at 11:00 a.m. Eastern Time to discuss the results. Interested parties can join the call telephonically by registering online to receive dial-in information and a unique pin. Additionally, a live audio webcast of the call will be accessible on the company's website at http://www.transdigm.com. For those unable to attend the live call, the webcast will be archived on the website and available for replay later that day.

TransDigm (NYSE: TDG) has completed the acquisition of the Electron Device Business from Communications & Power Industries for $1.385 billion in cash. This acquisition, originally announced in November 2023, was financed through cash on hand and proceeds from notes offerings. The acquired business specializes in high-engineering, proprietary electronic components and subsystems for the aerospace and defense sectors. Approximately 70% of its revenue comes from aftermarket services, with a total revenue of $300 million for the fiscal year ending September 29, 2023. The business operates in multiple locations and employs around 900 people.

Cerberus Capital Management has acquired Calspan's hypersonic and defense test systems business units from TransDigm Group (NYSE: TDG). The acquisition includes Calspan Aero Systems Engineering and Calspan Systems, resulting in the formation of North Wind, an independent business focusing on the advancement of U.S. hypersonic test capabilities.

North Wind, headquartered in St. Paul, Minnesota, will provide ground-based facility design, build and operations, testing, and analysis. This acquisition is part of Cerberus' strategy to address supply chain shortages and enhance U.S. national security. Key leadership includes David Meier as CEO, Stephanie Mumford as President of North Wind Systems, and Dr. Anthony Castrogiovanni as CTO.

This move aims to support U.S. defense infrastructure, with Cerberus providing resources and backing to drive innovation and resilience.

TransDigm Group (NYSE: TDG) announced it will host its 2024 Investor Conference on June 26, 2024, in New York City. The event will start at 9:00 a.m. and conclude by 2:00 p.m., featuring product presentations and breakout sessions, as well as a lunch.

Key presenters include CEO Kevin Stein, Co-COOs Mike Lisman and Joel Reiss, CFO Sarah Wynne, Executive Vice Presidents, and selected Operating Unit Management. Space is and advance registration is required via their website. The investor presentation will also be available on TransDigm's investor relations webpage.

L Squared Capital Partners has announced the pending sale of Raptor Scientific to TransDigm Group for $655 million in cash. This transaction, subject to customary closing conditions and regulatory approval, represents the ninth exit for L Squared since 2014 and the second in the last 45 days. Raptor Scientific has significantly grown its revenue from approximately $9 million to $90 million under L Squared's ownership, thanks to strategic investments and a strong management team. Raptor Scientific specializes in advanced test and measurement solutions for Defense, Space, and Aerospace applications. The acquisition is expected to provide Raptor Scientific with additional resources and scale to accelerate its growth. Both L Squared and TransDigm express optimism about the future collaboration.

TransDigm Group (NYSE: TDG) has agreed to acquire Raptor Scientific, a subsidiary of L Squared Capital Partners, for $655 million in cash, including tax benefits. Raptor Scientific manufactures complex test and measurement solutions for the aerospace and defense sectors. The acquisition is expected to generate around $90 million in revenue for the year ending December 31, 2024. Raptor Scientific employs about 170 people and operates in multiple locations across the United States. TransDigm's CEO, Kevin Stein, expressed that the acquisition aligns with their value generation strategy and is expected to meet long-term equity return objectives. The deal is pending regulatory approvals and is to be financed with existing cash.